Contrast mammogram for women with dense breasts
Part of Cancer, Skin clinical trials.
This study looks at whether contrast-enhanced mammography (CEM) can find breast cancer better in women who have dense breast tissue and a personal history of breast cancer. If you've had breast cancer before and have dense breasts, this trial could help improve early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between the ages of 50 and 69.
- You have dense breasts (category C or D) and a recent normal mammogram (BI-RADS 1 or 2).
- You have no history of kidney disease or have had your kidney function checked and it's normal.
- You are not allergic to iodine-based contrast dye used in CT scans or other imaging.
- You do not have thyroid disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a special mammogram with contrast can help assess breast cancer risk in women with dense breast tissue. It may help improve screening planning, especially when standard mammograms are harder to read due to density.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study tests whether a special type of mammogram (contrast-enhanced mammography, or CEM) can help doctors see additional breast findings that show up on MRI. It may help avoid unnecessary extra biopsies or surgeries.
This trial compares two imaging tests—CESM (a contrast-enhanced mammogram) and DBT (3D mammography)—to see which works best for women with dense breast tissue. It may help improve how early breast changes are found in dense breasts.
This trial offers extra screening (MRI or contrast-enhanced mammogram) for women with extremely dense breast tissue who have had a normal mammogram. The goal is to see if these extra tests can find cancers that might be missed by standard mammography.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.